FeesSafety
Pluang+

Class action lawsuit filed against Chemours for overstating product demand and misleading investors.

Market News
11 Oct 2026, 20:00 WIB
Newsfile Corp
View Source
Bearish
Class action lawsuit filed against Chemours for overstating product demand and misleading investors.

A class action lawsuit has been filed against Chemours Company and some of its officers for allegedly overstating demand for their Opteon products and providing misleading financial guidance during the period from February to August 2026. The lawsuit claims Chemours failed to disclose that demand was actually decreasing due to overselling in the previous year, which made their public statements false and misleading. Investors who purchased Chemours securities during this time are encouraged to join the case, with a deadline to request lead plaintiff status by December 7, 2026. The law firm Bronstein, Gewirtz & Grossman is representing investors on a contingency fee basis, meaning no upfront cost for investors.

The class action lawsuit involving Chemours Company provides context for market activity in the Basic Materials sector. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 12, 2026 00:11 WIB: out of 62 priced US stocks, 40 rose and 20 fell today. Notable movers include GGB at USD 5.12 with a 1-day change of +4.07%, CTVA at USD 13.22 with a 1-day change of -3.82% and 100% buy order activity, and AU at USD 94.16 with a 1-day change of +3.72% and 100% buy order activity.

More News

LUXEED's smart factory produces a vehicle every minute using AI and 880 robots for precision.

LUXEED's smart factory produces a vehicle every minute using AI and 880 robots for precision.

LUXEED showcased its Super Factory where over 2,000 intelligent devices and 880 robots work together to produce one vehicle every minute. The factory uses AI-driven automation for processes like welding and quality inspection, ensuring high precision...

Market News
Bullish
1 hour ago
Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris reports positive 30-day results for Medium-size DurAVR heart valve in severe aortic stenosis patients

Anteris Technologies announced favorable 30-day clinical outcomes for its Medium-size DurAVR Transcatheter Heart Valve (THV) in 22 patients with severe aortic stenosis. The valve showed excellent hemodynamics with low pressure gradients, large effect...

Market News
Bullish
4 hours ago
Devcon 8 Ethereum conference opens in Mumbai with key upgrade delays and staking debates

Devcon 8 Ethereum conference opens in Mumbai with key upgrade delays and staking debates

Devcon 8, Ethereum's flagship conference, runs from November 3-6, 2026, in Mumbai, India, marking the first time it's held there. Key topics include the delayed Glamsterdam upgrade with no new mainnet date, a critical roundtable on ETH issuance affec...

Protocol Fundamentals
Neutral
5 hours ago
LayerZero (ZRO) price rebounds above $1.80 amid new stablecoin partnership with Loon Finance

LayerZero (ZRO) price rebounds above $1.80 amid new stablecoin partnership with Loon Finance

LayerZero (ZRO) price recovered from a low of $1.41 on October 30 to trade above $1.80, surpassing key resistance levels including the 61.8% Fibonacci retracement at $1.51. The rebound was supported by a 9.8% rise in open interest and increased spot ...

Technical Signals
Bullish
5 hours ago
Morpho leads crypto decliners with 5.54% drop; Bitcoin and Ether gain slightly.

Morpho leads crypto decliners with 5.54% drop; Bitcoin and Ether gain slightly.

Morpho (MORPHO) fell 5.54% to $2.24, leading the largest crypto decliners over 24 hours as of Nov. 1. MemeCore also dropped 5.53% to $0.850. Among the top 90 cryptocurrencies, 49 declined while 41 rose. Bitcoin and Ether gained modestly by 1.04% and ...

Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App